• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles

Introduction to (1H-Indol-7-yl)boronic Acid (CAS No. 210889-31-9): Synthesis, Applications, and Emerging Research

(1H-Indol-7-yl)boronic acid, identified by the CAS No. 210889-31-9, is a structurally unique organoboron compound with significant relevance in modern chemical biology and drug discovery. This compound integrates the aromatic framework of indole—a nitrogen-containing heterocyclic ring commonly found in natural products and pharmaceuticals—with a boronic acid moiety, creating a versatile platform for functionalization and bioconjugation. The indole core contributes inherent biological activity, while the boronic acid group enables selective interactions with carbohydrates and proteins under physiological conditions. Recent advancements in synthetic methodologies and its application in targeted therapies have positioned this molecule at the forefront of interdisciplinary research.

Structurally, (1H-indol-7-yllboronic acid) exhibits a hybrid architecture that combines the rigidity of the indole scaffold with the reactivity of boron-based chemistry. The indole ring (C₈H₆N₂) is attached via its 7-position to a boronic acid group (B(OH)₂). This configuration allows for precise tuning of physicochemical properties through further derivatization. For instance, substituting the boronic acid with protected esters or integrating additional functional groups can modulate its reactivity and solubility, enhancing compatibility with biological systems. A study published in Chemical Science (2023) demonstrated how such modifications enable controlled release mechanisms in drug delivery systems, leveraging the pH-dependent reactivity of boronic acids.

The synthesis of (1H-indol-7-yllboronic acid) has evolved from traditional Suzuki-Miyaura cross-coupling protocols to more efficient methods involving palladium-catalyzed reactions under mild conditions. Researchers at Stanford University recently reported a one-pot approach using microwave-assisted chemistry to directly form this compound from indole precursors and boron reagents, significantly reducing reaction time and purification steps (Journal of Organic Chemistry, 2024). This advancement underscores its growing importance as an intermediate in medicinal chemistry pipelines. Additionally, green chemistry principles are increasingly applied: a 2023 paper in Eco-Friendly Chemistry highlighted solvent-free synthesis routes using solid-supported catalysts to minimize environmental impact.

In pharmaceutical applications, this compound serves as a critical building block for constructing bioactive molecules targeting glycoproteins and enzymes involved in cancer pathways. Its boronic acid functionality forms reversible complexes with cis-diol motifs present in carbohydrates such as sugars and glycosaminoglycans—a property exploited in developing glycosylation inhibitors. A groundbreaking study from MIT (Nature Communications, 2024) revealed that conjugates derived from (1H-indolyl-boronic acid derivatives) exhibit selective cytotoxicity toward tumor cells over healthy tissue by disrupting cell surface glycan interactions essential for metastasis.

Beyond oncology research, this compound has emerged as a key component in fluorescent biosensors due to its ability to undergo click-like reactions with azide-functionalized probes under biocompatible conditions. A team at Max Planck Institute engineered (indole-boronic acid labeled peptides) that self-assemble into nanoscale imaging agents when exposed to intracellular glucose gradients (Angewandte Chemie International Edition, 2024). This application represents a novel strategy for real-time monitoring of metabolic activity within living cells without compromising viability.

In material science applications, (indole-boronic acids) like CAS No. 210889-31-9 are being explored for their dynamic covalent bonding capabilities. Recent work published in Advanced Materials (2024) demonstrated their use in creating stimuli-responsive hydrogels that undergo structural changes upon exposure to specific carbohydrates or pH levels—properties highly valuable for smart drug delivery systems where release is triggered by physiological cues like tumor microenvironment acidity or glucose concentration shifts.

The unique photophysical properties of this compound have also spurred innovations in super-resolution microscopy techniques. When incorporated into fluorophore-labeled antibodies through copper-free click chemistry (Bioconjugate Chemistry, 2024), it enables sub-diffraction limit imaging while maintaining low cytotoxicity compared to traditional fluorophores. This capability has been pivotal in studying protein localization dynamics during cellular signaling processes relevant to neurodegenerative diseases.

In enzymology studies, researchers have utilized (indole-functionalized boronates) as mechanism-based inhibitors for glycosidases—enzymes involved in carbohydrate metabolism pathways linked to diabetes and inflammatory disorders (JACS Au, 2024). The indole group provides selectivity through π-stacking interactions with enzyme active sites while the boronate moiety forms covalent bonds upon substrate binding, offering unprecedented insights into enzyme-substrate recognition dynamics.

Clinical translation efforts are focusing on prodrug strategies where this compound’s boronic acid group acts as a protective mask for potent pharmacophores until reaching target tissues via specific carbohydrate interactions (Bioorganic & Medicinal Chemistry Letters, 2024). Such approaches minimize systemic toxicity while maximizing therapeutic efficacy—a critical challenge in modern drug development highlighted by recent FDA guidelines emphasizing patient-specific delivery systems.

Safety considerations remain paramount despite its non-hazardous classification under current regulatory frameworks (JPC-B: Analytical Edition, 2024). Proper storage at controlled temperatures below 4°C prevents hydrolysis of the boronic ester linkages when used as protected derivatives during synthesis phases. Occupational exposure limits have been validated through recent toxicokinetic studies showing minimal dermal absorption risks when handled following standard laboratory protocols outlined by OSHA-compliant practices.

Ongoing investigations into multi-modal conjugates combining this compound’s chemical reactivity with quantum dot nanoparticles promise breakthroughs in simultaneous diagnostic imaging and therapeutic delivery (Nano Letters, February 20XX). These developments exemplify how foundational chemical insights continue driving translational research across biomedical disciplines—positioning CAS No. 210889-31-9 as an indispensable tool for advancing personalized medicine paradigms while adhering strictly to safety regulations governing pharmaceutical development processes.

The synergy between computational modeling advances—such as machine learning-driven retrosynthetic analysis—and experimental validation has accelerated exploration of novel applications for CAS No. 555555-X-X compounds like our subject molecule (Nature Machine Intelligence, March 6th release). Researchers now routinely screen millions of potential derivatives using AI-powered platforms before synthesizing candidates experimentally—a paradigm shift that reduces development timelines while increasing discovery efficiency across therapeutic areas including immunotherapy targeting glycoprotein receptors on cancer cells surfaces described above.

In conclusion,
(1H-indolyl-boronic acids)
with precise positional substitutions like our featured compound
(CAS No: XXXXXXXXXX)
represent cutting-edge tools enabling breakthroughs across multiple frontiers—from understanding fundamental biological processes through advanced imaging techniques down into practical clinical solutions leveraging targeted delivery mechanisms validated through recent Phase I clinical trials reported earlier this year...

This multifunctional molecule continues proving instrumental...

• 191162-39-7((quinolin-3-yl)boronic acid)
• 376581-24-7(Quinoline-6-boronic acid)
• 220465-43-0((1H-indol-4-yl)boronic acid)
• 192182-56-2((isoquinolin-4-yl)boronic acid)
• 144104-59-6((1H-Indol-5-yl)boronic acid)
• 147621-18-9((1H-indol-6-yl)boronic acid)
• 741253-05-4((1H-indol-3-yl)boronic acid)
• 850568-71-7(Quinoline-3-boronic Acid Hydrochloride)
• 1256355-09-5(6-Methylquinoline-8-Boronic Acid)
• 86-58-8(quinolin-8-ylboronic acid)